Heron Therapeutics, Inc. (NASDAQ:HRTX) Q1 2024 Earnings Call Transcript insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.
SAN DIEGO, March 28, 2024 /PRNewswire/ Heron Therapeutics, Inc. , a commercial-stage biotechnology company, today announced that Craig Collard, Chief Executive Officer of Heron, will participate.
/PRNewswire/ Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced financial results.
/PRNewswire/ Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company, today announced that the company will host a conference call.